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Suppl. figure 1E-F. Resveratrol (RSV) intake in NAFL-R and NASH-R female and male rats.  
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Suppl. table 1. Diet formulas    
 
Diet name 
 
CD 
 
NAFL  
 
NAFL-R 
 
NASH 
 
NASH-R 
Open source ID D12450JY D12492 D13070207 D09052204 D09052206 
 
Energetic composition 
    
kJ/g 16.1 21.9 21.9 22.2 22.2 
Protein, kJ% 20 20 20 20 20 
Carbohydrate, kJ% 70 20 20 15 15 
Fat, kJ% 10 60 60 65 65 
 
Ingredients, kJ 
     
Casein, 30 Mesh 3347 3347 3347 3347 3347 
L-Cystine 50 50 50 50 50 
Corn Starch 8473 0 0 0 0 
Maltodextrin 10 2092 2092 2092 1632 1632 
Sucrose 1151 1151 1151 669 669 
Soybean Oil 941 941 941 941 941 
Lard 753 9226 9226 0 0 
Cocoa butter 0 0 0 10167 10167 
Vitamin Mix 
V10001 
167 167 167 167 167 
Cholesterol, g/kg 0.014 0.28 0.28 15.3 15.3 
Sodium Cholate 0 0 0 3.81 3.81 
Total kJ 16,958 16,958 16,958 16,958 16,958 
 
Fatty acid composition of fat sources 
   
  Soybean oil Lard Cocoa butter  
Polyunsaturated 
fatty acids (PUFAs) 
 
 58% 
 
11% 3.3%   
Monounsaturated 
fatty acids 
(MUFAs) 
 
 23% 
 
45% 34.9%  
Saturated fatty acids  16% 39% 61.6%  
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Suppl. table 2 Primer sequences 
Gene Sense 5’-3’ Antisense 5’-3’ 
COL1α1 AGCATGTCTGGTTTGGAGAGAGC CCTTCGCTTCCATACTCGAACTGG 
TGFβ1 TTTGACGTCACTGGAGTTGTCC CGAAAGCCCTGTATTCCGTCTC 
TNFα CTGTGAGGCGACTGGCGTGTT GAGCCCGGAGTTGGACC 
UCP2 TGGTTTCAAGGCCACCGATGTTG CCTTGACTCTCTCCTTGGATCTGC 
SIRT1 CGATGACAGAACGTCACACGC TCGAGGATCGGTGCCAATCA 
PGC-1α CCGTAAATCTGCGGGATGATGGAG AGCGTCACAGGTGTAACGGTAG 
SREBP-1c CCCAGGGCAGCTCTGTACTCC AAGCTGTCCCGCAGGTA 
18s TGGATACCGCAGCTAGGAAT AACTACGACGGTATCTGATC 
COL1α1, collagen1α1; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1α; SIRT1, 
silent mating type information regulation 2 homolog 1; SREBP-1c, sterol regulatory element-binding 
protein-1c; TGFβ1, transforming growth factor β1; UPC2, uncoupling protein 2. 
 
 
Supplementary information 
Methods 
 
Study animals, interventions and procedures 
Females weighed 211 (± 6) and males weighed 243 (± 3) grams at study start (Table 1). The rats 
were kept on a regular 12-hour light/dark cycle under controlled temperature conditions (21 ± 2 
°C). Throughout the 8-week study, animals were weighed and food consumption was registered 
weekly. At the end of experiment, the animals were anesthetized, and blood was collected and the 
liver removed, weighed and processed for further analysis. Relative liver weight was calculated as 
liver weight/BW * 100. 
We did not observe any overt signs of adverse effects in the RSV-treated groups. 
 
Details on RT-PCR analysis 
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Liver total RNA was isolated using the Qiagen RNeasy Lipid Tissue Kit (cat. no. 74804), according 
to the manufacturer’s instructions, and quantified using a NanoDrop 8000 spectrophotometer 
(Thermo Scientific Inc., MA, USA). For quantitative real-time polymerase chain reaction (qRT-
PCR), cDNA was synthesized using random hexamer primers (Verso cDNA kit, Thermo Fisher 
Scientific Inc.). The specificity of the primers was tested by melting curve analysis and agarose gel 
electrophoresis. The reactions were performed in duplicate using the KAPA SYBR FAST qPCR kit 
(Kapa Biosystems, Inc., Woburn, MA, USA) in a LightCycler 480 (Roche Applied Science). The 
relative gene expression was estimated using the default “Advanced Relative Quantification” mode 
of the software version LCS 480 1.5.0.39 (Roche Applied Science). Housekeeping gene 18s was 
used as internal control, and showed stable expression. 
 
Details on measurement of RSV metabolites 
Samples from the male CD group were used as the negative control. 
 
Extraction of serum 
100 µl serum was extracted with 400 µl acetonitrile (ACN), mixed, and centrifuged at 1000 rpm for 
10 min. The supernatant was evaporated, re-dissolved in 100 µl ACN, and used for analysis by 
liquid chromatography-tandem mass spectrometry (LC-MS/MS).  
 
Extraction of liver samples 
100 mg liver sample was macerated using liquid nitrogen and extracted with 1 ml ACN, mixed and 
centrifuged at 1000 rpm for 10 min. The supernatant was evaporated, re-dissolved in 100 µl ACN, 
and used for analysis by LC-MS/MS. 
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LC-MS/MS analysis 
LC-MS/MS analysis was performed on a LTQ XL (Linear Quadrupole 2D Ion Trap Mass 
Spectrometer, Thermo Scientific, CA, USA) mass spectrometer operating in atmospheric-pressure 
chemical ionization (APCI) positive mode and attached to an Accela HPLC system. Settings for the 
mass spectrometer were 50, 5, and 5 (arbitrary units) for sheath, auxiliary, and sweep gas flow rates 
(N2), respectively, a spray voltage of 6 kV, and a capillary temperature of 275 °C. The settings for 
capillary voltage and tube lens voltage were 11 V and 10 V, respectively. RSV metabolites were 
separated by a solvent gradient with aqueous formic acid (0.1%, pH 2.5) as solvent A and 100% 
acetonitrile as solvent B on a Kinetex C18 reverse-phase column (100 mm length, 2.1 mm internal 
diameter, 1.7 µm particle size; Phenomenex) protected by a precolumn. Solvent gradient: 0 min 5% 
B, 2 min 5% B, 8 min 30% B, 11 min 95% B, 14 min 95% B and then equilibrating the column at 
5% B for 5 min., the flow rate was 0.2 ml/min. and the column temperature was 25 
o
C. RSV 
metabolites were identified based on their full scan MS and MS/MS spectra generated in APCI 
positive mode by comparing with authentic standards isolated previously from human urine [1] 
and/or mass spectra from the literature [2, 3]. RSV metabolites were quantified by an external 
standard calibration curve of trans-resveratrol. Further, the molecular weight (MW) of the 
individual RSV metabolites was included in the calculations of their concentrations, taking into 
account their different MWs compared to that of trans-resveratrol (MW 228). Consequently, 
different conversion factors for the identified RSV were used: trans-dihydroresveratrol (MW 230), 
trans-resveratrol sulfates (MW 308), trans-dihydroresveratrol sulfates (MW 310), trans-resveratrol 
glucuronides (MW 404), trans-dihydroresveratrol glucuronides (MW 406), and trans-resveratrol-
diglucuronide (MW 580).  
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